Unlocking Novel Chemistry
Designing Better Therapeutics
Ansaris was established in February 2009 to focus on small molecule drug discovery challenges, by leveraging 10 years of drug discovery expertise:
- Fragment-based drug design technology from Sarnoff Corporation
- Protein modeling technology from Protein Mechanics, Inc
- Evolution of technologies into next generation and advancement of drug candidates into development from Locus Pharmaceuticals
Recent News
-
American Chemical Society 2010 National Meeting & Exposition
-
5th Annual Protein Kinases in Drug Discovery Conference
- May 3, 2010
2010 BIO International Convention
-
Bio-IT World Conference & Expo 2010
-
New Directions in Small Molecule Drug Discovery
- Keystone Symposium on Computer-Aided Drug Design